Found: 15
Select item for more details and to access through your institution.
The application of prescribing indicators to a primary care prescription database in Ireland.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 127, doi. 10.1007/s00228-004-0876-3
- By:
- Publication type:
- Article
In response to Vannacci, “Publication bias in complementary and conventional medicine”.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Co-prescription ofcytochrome<sub>P450</sub> 2D6/3A4 inhibitor-substrate pairs in clinical practice. A retrospective analysis of data from Norwegian primary pharmacies.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 119, doi. 10.1007/s00228-004-0877-2
- By:
- Publication type:
- Article
Single nucleotide polymorphisms ofABCB1(MDR1) gene and distinct haplotype profile in a West Black African population.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 97, doi. 10.1007/s00228-004-0879-0
- By:
- Publication type:
- Article
Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 103, doi. 10.1007/s00228-004-0887-0
- By:
- Publication type:
- Article
Incidence of drug-induced liver injury in medical inpatients.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 135, doi. 10.1007/s00228-004-0888-z
- By:
- Publication type:
- Article
Patient characteristics associated with prescribing of a newly introduced drug: the case of rofecoxib.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 157, doi. 10.1007/s00228-005-0891-z
- By:
- Publication type:
- Article
Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 87, doi. 10.1007/s00228-005-0893-x
- By:
- Publication type:
- Article
A population approach to study the influence of nevirapine administration on lopinavir pharmacokinetics in HIV-1 infected patients.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 153, doi. 10.1007/s00228-005-0900-2
- By:
- Publication type:
- Article
Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 145, doi. 10.1007/s00228-005-0897-6
- By:
- Publication type:
- Article
Clinical trials of medication in children, 1996-2002.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Food-drug interactions in the summary of product characteristics of proprietary medicinal products.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 77, doi. 10.1007/s00228-004-0846-9
- By:
- Publication type:
- Article
Designing the most favourable study design.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 85, doi. 10.1007/s00228-005-0895-8
- By:
- Publication type:
- Article
Publication bias in complementary and conventional medicine.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Alprazolam as a probe for CYP3A using a single blood sample: pharmacokinetics of parent drug, and of a- and 4-hydroxy metabolites in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 2, p. 113, doi. 10.1007/s00228-004-0861-x
- By:
- Publication type:
- Article